Delivery Order SPE2DB22D3401-SPE2DB25FT3HB

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,862,352 units of Epinephrine 0.3 mg auto-injector devices. The delivery order, valued at $1,274.76, is a firm-fixed-price contract with a completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,190,754 units of Epinephrine 0.3 mg auto-injectors. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,874,699 units of Epinephrine 0.3 mg auto-injectors, with a ceiling value of $16,738.41 and a performance period through April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,923,953 units of Epinephrine 0.3 mg auto-injectors, with a ceiling value of $3,736.58 and a period of performance ending on April 16, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a delivery order worth $2,875.50 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,837,064 units of Epinephrine 0.3 mg auto-injectors. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,224.92 firm fixed price contract is for the procurement of 4,567,731,408 units of epinephrine 0.3 mg auto-injectors. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,844,576 units of Epinephrine 0.3 mg auto-injectors. The fixed-price contract has a ceiling value of $8,884.54 and a completion date of September 18, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a $4,377.38 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,617,803 units of Epinephrine 0.3 mg auto-injectors. The order has an ultimate completion date of August 29, 2024 and was awarded on August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,405,877 units of Epinephrine 0.3 mg auto-injectors. The contract is a firm fixed-price agreement with a ceiling value of $10,193.84 and a performance period ending on August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
This is a $4,424.13 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,565,632,324 units of epinephrine 0.3 mg auto-injector, with a performance period through August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a comprehensive range of...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT3HB
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,066,406 units of Epinephrine 0.3 mg Auto-Injectors. The contract has a firm fixed price of $1,477.10 and a period of performance through April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs. The contract is not designated as a set-aside and is open to full and open competition.

Generated 7/22/25, 10:12 AM